Global Health was incorporated on August 13, 2004. The company is a multi-speciality tertiary care provider operating in the north and east regions of India. The speciality segments involve cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.
| Bidding Dates |
|---|
| 03 Nov 2022 - 07 Nov 2022 |
| Subscription |
|---|
| 9.58x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹14,784 | 1 | 13 | 44 | 65.6 M | ₹319 - ₹336 | 75.52 % | ₹20939.8 M - ₹22055.7 M | RHP DOC |
Global Health IPO SUBSCRIPTION STATUS
07 Nov '22Global Health IPO overall subscription rate was 9.58 times the total available shares
Global Health IPO retail subscription rate was 0.88 times in the retail segment
Global Health IPO non-institutional investor subscription rate was 4.02 times in the non-institutional investor category
Global Health IPO Qualified Institutional Bidder subscription rate was 28.64 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
07 Nov 2022 (Day 3) | 0.88x | 4.02x | 28.64x |
04 Nov 2022 (Day 2) | 0.25x | 0.96x | 0.56x |
03 Nov 2022 (Day 1) | 0.12x | 0.18x | 0.54x |
Global Health FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) |
| Q1FY23 | 587.1 | 6,172.1 | 1,376.4 | 1,002.1 |
| Q1FY22 | 417.6 | 4,854.9 | 764.6 | 260.7 |
| FY22 | 1,962.0 | 21,665.9 | 3,112.6 | 367.9 |
| FY21 | 288.1 | 14,467.4 | 2,417.7 | 960.3 |
| FY20 | 363.3 | 15,004.2 | 1,750.7 | -132.0 |
Global Health IPO SUBSCRIPTION STATUS DETAILS
Global Health had 65.6 M shares on offer
Global Health IPO offer price was in the range ₹319 - ₹336
Global Health IPO minimum Investment was ₹14784
Global Health IPO issue size was ₹ 20939.8 M - ₹ 22055.7 M
Global Health had a minimum lot size of 44 Shares per application
Global Health NUMBER OF SHARES ON OFFER
Global Health IPO IMPORTANT DATES
| Issue Open Date | 03 Nov 2022 |
| Issue close Date | 07 Nov 2022 |
| Allotment Date | 11 Nov 2022 |
| Refund Date | 14 Nov 2022 |
| Demat Account Credit Date | 15 Nov 2022 |
| Listing Date | 16 Nov 2022 |
| Listing on Exchange(s) | NSE and BSE |
| Global Health Allotment Status | Exchange |
Global Health IPO subscription opened on 03 Nov 2022, and closed on 07 Nov 2022
IPO allotment for Global Health was finalized on Friday, 11 Nov 2022
IPO listing for Global Health was on NSE and BSE on Wednesday, 16 Nov 2022
Global Health IPO LISTING GAINS
| Issue Price (adjusted) | 336.0 |
| Listing Open Price | 401.0 |
| Listing Close Price | 415.3 |
| Listing Gain% | 19.4% |
| Current Gain% | 333.2% |
Global Health Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Health Ltd. | 1455.6 | 39037 | 70.4 | 17.1 | 8.4 | 14 | 9.4 | 4508.9 | 19.6 | 556.5 | 15.6 | 20.7 | 4.1 |
| Apollo Hospitals Enterprise Ltd. | 8945 | 128615.4 | 66.2 | 1.9 | 5.1 | 20.5 | 8.7 | 25420.1 | 15.6 | 1941.7 | 34.3 | 135 | 34.3 |
| Max Healthcare Institute Ltd. | 1070 | 104140.3 | 72.2 | 2.1 | 12.4 | 13.4 | 8.4 | 8536.1 | 18.8 | 1442.4 | 34.1 | 14.8 | 34.1 |
| Manipal Health Enterprises Ltd. | 678 | 89176 | 10.6 | 3.6 | 10520.5 | 25.8 | 892.3 | -16.2 | |||||
| Fortis Healthcare Ltd. | 955.2 | 72109.8 | 68.8 | 3.3 | 7.6 | 10.5 | 6.5 | 9178.5 | 16.9 | 1041.8 | 34.6 | 13.9 | 20.7 |
| Aster DM Quality Care Ltd. | 869.7 | 45061 | 141.4 | 882.1 | 9.2 | 8.5 | 4.8 | 4768.8 | 11.2 | 388.1 | -92.8 | 6.2 | 0.2 |
Global Health IPO Reports
Global Health INFORMATION ON IPO ISSUE
About Global Health
Global Health was incorporated on August 13, 2004. The company is a multi-speciality tertiary care provider operating in the north and east regions of India. The speciality segments involve cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.
Object of the Issue
- Repayment/prepayment of borrowings, in full or part, of the subsidiaries—GHPPL and MHPL
- General corporate purposes
Global Health - PROMOTERS
| Name |
|---|
| Naresh Trehan |
Global Health Book Running Lead Manager
Kotak Mahindra Capital Company Limited
globalhealth.ipo@kotak.com
Global Health Book Running Lead Managers
Credit Suisse Securities (India) Private Limited
list.medantaipo2021@credit-suisse.com
Jefferies India Private Limited
medanta.ipo@jefferies.com
JM Financial Limited
ghl.ipo@jmfl.com
Global Health Registrar to the Offer
KFinTechnologies Private Limited
globalhealth.ipo@kfintech.com
Global Health Strengths
Recognised for clinical expertise
The company is a tertiary and quaternary care provider in India, recognised for clinical expertise in dealing with complicated cases
Focus on clinical research and academics
The company is focused on clinical research and academics and its clinical research facility, established in 2009, is another driving force behind the high standard of care
Skill and experience
‘Doctor-led’ hospitals driven by skilled and experienced doctors in the healthcare space
Large-scale hospitals
The company has large-scale hospitals with sophisticated infrastructure, medical equipment and technology
Track record of operational and financial performance
The company has consistently delivered high operational and financial performance through high patient volumes, cost efficiency and diversified revenue streams across medical specialities
Global Health Risks
Financial ratios underperform industry
The company's total income, earnings per share, net asset value, return on net worth, net profit margin and return on capital employed, price-to-earnings ratio, enterprise value to EBITDA ratio, and market capitalisation to total income ratio may be less than that of some of the listed comparable industry peer
Covid-19
Stringent restrictions to slow down the spread of Covid-19, including limitations on international and local travel, had and could continue to have a negative impact on business
Subsidiaries incurred losses
Subsidiaries, MHPL and GHPPL, have incurred losses in the preceding fiscals and may incur losses in the future
Healthcare services has high costs
The provision of healthcare services has high costs such as manpower cost, infrastructure maintenance and repair cost, and high medical equipment cost and any failure to pass on such costs to the patients may have a material adverse impact on business, financial condition, results of operations and prospects
IPO FAQs
This IPO consists of an offer for sale of up to Rs 1,705.6 crore, of 50,761,000 shares. It also consists of a fresh issue of Rs 500.0 crore.
The promoter of the company is Naresh Trehan.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 319.0 - 336.0.
The IPO application opens on Nov 03, 2022 and closes on Nov 07, 2022.
The minimum lot size for the IPO is 44. The maximum lot size for the IPO is 572.
For all category investors, the minimum application amount for this IPO is Rs. 14,784.0, the maximum value for this IPO is Rs 192,192.0.
This IPO will be allotted on Nov 11, 2022.
The refund will be credited to your account on Nov 14, 2022.
The allotted shares will be credited to your demat on Nov 15, 2022.
Global Health Ltd.’s shares listed on the stock exchanges on Nov 16, 2022.